Abbott Wins Antitrust Challenge Over HIV Drug Cocktail
When patent owners raise prices and make combination products more expensive in the process, they cannot be sued for monopoly leveraging under U.S. antitrust laws, according to a ruling Wednesday by...To view the full article, register now.
Already a subscriber? Click here to view full article